جدول الترويج NeuroPace, Inc.
الجدول الزمني المتقدم
رسم بياني بسيط
عن الشركة
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. مزيد من التفاصيل| Цена ао | 13.33 |
|---|---|
| Выручка | 0.037 |
| EBITDA | -0.0201 |
| P/S | 5.46 |
| P/BV | 3.35 |
| EV/EBITDA | -2.92 |
| ISIN | US6412881053 |
| Сайт | https://www.neuropace.com |
| Число акций ао | 0.02585 млрд |
| Валюта | usd |
| IPO date | 2021-04-22 |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Валюта отчета | usd |
| تغير السعر يوميا: | -0.9288% (6.46) |
|---|---|
| تغير السعر في الأسبوع: | +4.75% (6.11) |
| تغير السعر شهريا: | -13.86% (7.43) |
| تغير السعر خلال 3 أشهر: | -12.33% (7.3) |
| تغير السعر على مدى ستة أشهر: | -54.22% (13.98) |
| تغير السعر سنويا: | +4.07% (6.15) |
| تغير السعر على مدى 3 سنوات: | -61.26% (16.52) |
| تغير الأسعار منذ بداية العام: | -26.35% (8.69) |
|
|
الاستهانة
|
كفاءة
|
|||||||||||||||||||||||||||||||||||||
توزيعات الأرباح
|
واجب
|
دافع النمو
|
|||||||||||||||||||||||||||||||||||||
| المؤسسات | مقدار | يشارك, % |
|---|---|---|
| KCK Limited | 5621111 | 21.39 |
| Orbimed Advisors LLC. | 4003967 | 15.23 |
| Morgan Stanley | 2460716 | 9.36 |
| Soleus Capital Management, L.P. | 2433168 | 9.26 |
| Nantahala Capital Management, LLC | 2347354 | 8.93 |
| Kent Lake Capital, LLC | 670946 | 2.55 |
| FMR, LLC | 468081 | 1.78 |
| Vanguard Group Inc | 413106 | 1.57 |
| Millennium Management LLC | 172403 | 0.66 |
| Geode Capital Management, LLC | 115996 | 0.44 |
| ETF | يشارك, % | الربحية لهذا العام, % | توزيعات الأرباح, % |
|---|---|---|---|
| ProShares Hedge Replication ETF | 0.00058 | 5.9237999659878 | 1.47892 |
| iShares Micro-Cap ETF | 0.02573 | 34.327031588619 | 1.54048 |
| iShares Russell 2000 Growth ETF | 0.00726 | 38.042556988 | 0.6026 |
| ProShares UltraPro Russell2000 | 0.0022 | 89.821266282945 | 1.47873 |
| Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 37.361289927043 | 0.60264 |
| Vanguard Russell 2000 ETF | 0 | 32.773459189339 | 1.48801 |
| مشرف | مسمى وظيفي | قسط | سنة الميلاد |
|---|---|---|---|
| Dr. Martha J. Morrell | Chief Medical Officer | 728.68k | 1957 (67 سنين) |
| Mr. Joel D. Becker | CEO, President & Director | 762k | 1968 (56 سنين) |
| Ms. Rebecca L. Kuhn | CFO, VP of Finance & Administration, Corporate Secretary and Assistant Secretary | 614.91k | 1961 (63 سنة) |
| Ms. Kelley Nicholas | Vice President of Sales | N/A | |
| Ms. Leah Akin | Acting General Counsel | N/A | |
| Mr. Dylan St. John | Chief of Operations & Development |
عنوان: United States, Mountain View. CA, 455 North Bernardo Avenue - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://www.neuropace.com
موقع إلكتروني: https://www.neuropace.com
